Review



computer-based eye-tracking analysis  (King Devick Technologies Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    King Devick Technologies Inc computer-based eye-tracking analysis
    Division of participants into <t>analysis</t> groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All <t>eye-tracking</t> (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
    Computer Based Eye Tracking Analysis, supplied by King Devick Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/computer-based eye-tracking analysis/product/King Devick Technologies Inc
    Average 90 stars, based on 1 article reviews
    computer-based eye-tracking analysis - by Bioz Stars, 2026-04
    90/100 stars

    Images

    1) Product Images from "Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease"

    Article Title: Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease

    Journal: Journal of Alzheimer's Disease

    doi: 10.3233/JAD-215551

    Division of participants into analysis groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All eye-tracking (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
    Figure Legend Snippet: Division of participants into analysis groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All eye-tracking (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.

    Techniques Used: Control, Battery

    King-Devick (KD) reading test scores and related eye-tracking (ET) recordings
    Figure Legend Snippet: King-Devick (KD) reading test scores and related eye-tracking (ET) recordings

    Techniques Used:



    Similar Products

    computer-based eye-tracking analysis  (King Devick Technologies Inc)
    90
    King Devick Technologies Inc computer-based eye-tracking analysis
    Division of participants into <t>analysis</t> groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All <t>eye-tracking</t> (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.
    Computer Based Eye Tracking Analysis, supplied by King Devick Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/computer-based eye-tracking analysis/product/King Devick Technologies Inc
    Average 90 stars, based on 1 article reviews
    computer-based eye-tracking analysis - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Division of participants into analysis groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All eye-tracking (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.

    Journal: Journal of Alzheimer's Disease

    Article Title: Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease

    doi: 10.3233/JAD-215551

    Figure Lengend Snippet: Division of participants into analysis groups. A) Non-demented participants underwent testing and were divided into control and mild cognitive impairment (MCI) groups. The Alzheimer’s disease (AD) group was confirmed similarly. B) Quality control of analysis groups. All eye-tracking (ET) data went through quality control and recordings with < 60% success rate were disqualified. All audio recordings went through quality control, with garbled or silent recordings being disqualified before the automated King-Devick (KD) results analysis. CERAD-NB, Consortium to Establish a Registry for Alzheimer’s Disease –neuropsychological test battery; CDR, clinical dementia rating; QC, quality control. * One participant from the KD MCI group was removed from the KD analysis due to an excessive number of errors (> 30) made in the last KD card, as they read the test in vertical columns instead of horizontal rows.

    Article Snippet: To examine whether computer-based eye-tracking (ET) analysis of King-Devick (KD) test results differentiates cognitively healthy persons from persons with minor problems in cognitive testing or diagnosed mild AD.

    Techniques: Control, Battery

    King-Devick (KD) reading test scores and related eye-tracking (ET) recordings

    Journal: Journal of Alzheimer's Disease

    Article Title: Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease

    doi: 10.3233/JAD-215551

    Figure Lengend Snippet: King-Devick (KD) reading test scores and related eye-tracking (ET) recordings

    Article Snippet: To examine whether computer-based eye-tracking (ET) analysis of King-Devick (KD) test results differentiates cognitively healthy persons from persons with minor problems in cognitive testing or diagnosed mild AD.

    Techniques: